Global Cataract Surgery device Market Size, Share, Forecast Report, 2020-2027

The globally market for cataract surgery device is growing steadily. Factors that influence the cataract surgery device market are increasing prevalence of cataract surgery, increasing advance technology in cataract surgery device market, increase in the aging population, prevalence of eye disease and many others. Globally the market for cataract surgery device is expected to grow at the rate of about 5.5% from 2016 to 2022.

Key Finding

The cataract surgery device global market is expected to reach $4.5 billion by 2022.
Intraocular lens (IOL) holds the largest share of 79% of the cataract surgery device market.
North America holds the largest market share of around 46% of cataract surgery device.
Asia Pacific is expected to be the fastest growing market at a CAGR of 5.5%

Key Players for Cataract Surgery device Market:
Some of the key players in this market are: Alcon, Inc. (U.S), Abbott Laboratories (U.S.), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), Opcon Corporation (Japan), Allergan, Inc. (U.S.), Bausch & Lomb, Inc. (U.S.), NIDEK Co., Ltd. (Japan), STAAR Surgical Company (U.S.) and others.

Market Segments:
Global Cataract Surgery device market has been segmented on the basis of device type which comprises of intraocular lens (IOL), ophthalmic viscoelastic device (OVD), phacoemulsification equipment and femtosecond laser equipment.
Furthermore on the basis of end user the market is segmented into ophthalmology centers, hospitals, clinics and others.